Search by Drug Name or NDC

    NDC 00037-6860-10 Dipentum 250 mg/1 Details

    Dipentum 250 mg/1

    Dipentum is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Meda Pharmaceuticals Inc.. The primary component is OLSALAZINE SODIUM.

    Product Information

    NDC 00037-6860
    Product ID 0037-6860_f463a4ea-ba23-47da-af7f-92c2d7367a82
    Associated GPIs 52500040100120
    GCN Sequence Number 015514
    GCN Sequence Number Description olsalazine sodium CAPSULE 250 MG ORAL
    HIC3 D6F
    HIC3 Description DRUG TX-CHRONIC INFLAM. COLON DX,5-AMINOSALICYLAT
    GCN 33401
    HICL Sequence Number 005889
    HICL Sequence Number Description OLSALAZINE SODIUM
    Brand/Generic Brand
    Proprietary Name Dipentum
    Proprietary Name Suffix n/a
    Non-Proprietary Name olsalazine sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, GELATIN COATED
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name OLSALAZINE SODIUM
    Labeler Name Meda Pharmaceuticals Inc.
    Pharmaceutical Class Aminosalicylate [EPC], Aminosalicylic Acids [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA019715
    Listing Certified Through 2024-12-31

    Package

    NDC 00037-6860-10 (00037686010)

    NDC Package Code 0037-6860-10
    Billing NDC 00037686010
    Package 100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0037-6860-10)
    Marketing Start Date 2015-05-15
    NDC Exclude Flag N
    Pricing Information N/A